Influence of grapefruit juice on cisapride pharmacokinetics

Gross, Annette S.; Goh, Yan D.; Addison, R. S.; Shenfield, Gillian M.

doi:10.1016/s0009-9236(99)70133-5

Cited by 56 publications

(44 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The mean C max increased 160%, and the AUC increased 190%. The effect of grapefruit juice on the bioavailability of praziquantel showed an interindividual variability similar to that found with other drugs (11,13).…”

supporting

confidence: 76%

“…No statistically significant differences were found in the time to maximum concentration of drug in plasma or elimination half-life.Grapefruit juice increases the bioavailability of a variety of drugs (3,4,10,11,13,14,18), but it scarcely affects the elimination half-life (t 1/2 ). These findings suggest that grapefruit juice alters the first-pass metabolism mainly by suppression of the cytochrome P450 enzyme CYP3A4 in the small intestine (1,2,15).…”

mentioning

confidence: 99%

See 1 more Smart Citation

Interaction between Grapefruit Juice and Praziquantel in Humans

Castro

Jung

Medina

et al. 2002

Antimicrob Agents Chemother

View full text Add to dashboard Cite

After a single oral dose of praziquantel with 250 ml of grapefruit juice, the area under the concentration-time curve and the maximum concentration in plasma of praziquantel (C max ) were significantly increased (C max for water treatment, 637.71 ؎ 128.5 ng/ml; and C max for grapefruit juice treatment, 1,037.65 ؎ 305.7 ng/ml, P < 0.05). No statistically significant differences were found in the time to maximum concentration of drug in plasma or elimination half-life.Grapefruit juice increases the bioavailability of a variety of drugs (3,4,10,11,13,14,18), but it scarcely affects the elimination half-life (t 1/2 ). These findings suggest that grapefruit juice alters the first-pass metabolism mainly by suppression of the cytochrome P450 enzyme CYP3A4 in the small intestine (1,2,15).Praziquantel is an effective antihelmintic drug, widely used in the treatment of various parasitic diseases, including brain cysticercosis (7,20). It has been shown that the drug undergoes extensive metabolism by cytochrome P450; therefore, the systemic bioavailability of praziquantel is low and variable despite its almost complete gastrointestinal absorption (17). The specific cytochrome P450 enzymes involved in the metabolism of praziquantel in humans have not been characterized (5), but a significant inhibition of praziquantel hydroxylation by compounds that are inhibitors for 3A isoforms of cytochrome P450 has been observed in microsomes isolated from rat liver (16). In previous studies in humans, it was shown that cimetidine (an inhibitor of the microsomal cytochrome P450 mixed-function oxidase system) or simultaneous food administration increased the levels in plasma of praziquantel (6, 12); therefore, the aim of this study was to investigate the effect of the ingestion of grapefruit juice on the pharmacokinetics of praziquantel.Eighteen healthy male volunteers (age range, 23 to 37 years; mean, 28.8 Ϯ 5.4 years) participated in the study. Medical examination before the study showed that they were healthy and had normal results in laboratory tests that included complete blood count, serum chemistry measurement, hepatic test, and urinalysis. The volunteers signed an informed consent after detailed explanation about the purpose and design of the study, as well as the possible risks. The study was approved by the local ethics committee.The study was performed using a balanced randomized crossover design. Volunteers were separated in two groups of nine subjects each and received three tablets of 600 mg of praziquantel (Cisticid; Merck) with 250 ml of water or 250 ml of commercially squeezed grapefruit juice (Florida 7; lot L-2 05:51; Zano Alimentos S.A. de C.V., Mexico City, Mexico).The same lot number was used throughout the study. The interval between tests was 1 week. Blood samples were obtained through an indwelling catheter placed in the antecubital vein at 0.0, 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 6.0, and 8.0 h after the drug administration. Samples were centrifuged; the plasma was separated and stored at Ϫ4°C until an...

show abstract

supporting

confidence: 76%

mentioning

confidence: 99%

Interaction between Grapefruit Juice and Praziquantel in Humans

Castro

Jung

Medina

et al. 2002

Antimicrob Agents Chemother

View full text Add to dashboard Cite

show abstract

“…CYP3A4 is the primary mode of elimination of cisapride (Bohets et al, 2000). In two different studies, 250 ml of grapefruit juice ingested concomitantly with a 10 mg dose of cizapride caused a 50% increase in the bioavailability of cizapride (Gross et al, 1999;Offman et al, 2001). In another study, high doses of grapefruit juice were used and similar outcomes have been reported .…”

Section: Sildenafilmentioning

confidence: 70%

Food–drug interaction: grapefruit juice augments drug bioavailability—mechanism, extent and relevance

2003

View full text Add to dashboard Cite

More than a decade has passed since it was unintentionally discovered that grapefruit juice interacts with certain drugs. The coadministration of these drugs with grapefruit juice can markedly elevate drug bioavailability, and can alter pharmacokinetic and pharmacodynamic parameters of the drug. The predominant mechanism for this interaction is the inhibition of cytochrome P-450 3A4 in the small intestine, resulting in a significant reduction of drug presystemic metabolism. An additional mechanism is, presumably, the inhibition of P-glycoprotein, a transporter that carries drug from the enterocyte back to the gut lumen, resulting in a further increase in the fraction of drug absorbed. Some calcium channel antagonists, benzodiazepines, HMG-CoA reductase inhibitors and cyclosporine are the most affected drugs. A single exposure to one glass of the juice can usually produce the maximal magnitude of the interaction. The data available so far, concerning this interaction and its clinical implications, are reviewed in this article. It is likely that more information regarding this interaction will accumulate in the future, and awareness of such is necessary for achieving optimal drug therapy.

show abstract

“…Cisapride pharmacokinetics have mainly been studied in adults [15,16,17,18]. Bioavailability is 40% to 50% when the drug is administered 15 min before meals, and maximal concentration is obtained in 1 h to 2 h [15].…”

Section: Introductionmentioning

confidence: 99%